Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2015-03-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Implementation of Problem Management Plus (PM+) in Adult Syrian Refugees in Turkey: Pilot
NCT03567083
Implementing Psychosocial Interventions to Syrian Refugee Women Who Are Exposed to Psychological Trauma
NCT03912077
Improving Emotional Wellbeing of University Students: Anxiety Management
NCT07096154
The Effectiveness of a CA-CBI on Psychological Distress of University Students During the COVID-19 Pandemic
NCT04858789
The Delivery of "Doing What Matters in Times of Stress: An Illustrated Guide"
NCT04631887
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Chi square test and independent t-test for dependent variables were run beforehand to check if participants were equally distributed to Bias Modification group-E and group-C. No statistically significant difference between group-E and group-C was observed with regards to gender distribution, social anxiety, anxiety, depression, dysfunctional thoughts, automatic thoughts, and attentional and interpretational biases.
To see the effect of 8 sessions of manipulation on attentional and interpretational bias (independent variable) created a significant difference between experimental and control groups, 2 (group: experimental \[E\] and control \[C\]) × 3 (time: pre \[t1\] / post \[t2\] / follow-up \[t3\]) mixed ANOVA was conducted for each dependent variable in self-report measurements, and 2 (group: experimental \[E\] and control \[C\]) × 2 (time: pre \[t1\] / post \[t2\]) mixed ANOVA were conducted for attentional and interpretational biases.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cognitive Bias Modification (Group-E)
Participants were subjected to Combined Cognitive Bias Modification in each session. During the attentional bias modification phase, photographs of neutral or threatening (disgusted) faces were used. In each trial, a pair was shown for 500 ms. Then, a sign of arrow appeared and participants were asked to indicate the direction of the arrow. In %80 of the trials, the arrow was in the same area with the neutral photograph. During the interpretational bias modification phase a threatening or positive word, as the interpretation of a sentence, appeared, then, a relevant sentence with ambiguous meaning appeared, and later, participants were asked to indicate if the word and the sentence were related. After their response a feedback (right/wrong) was given and the next trial was started.
Combined Cognitive Bias Modification
Placebo Control (Group-C)
Participants in this group were subjected to the same procedure as the experimental group. However, during the Combined Cognitive Bias Modification process, the sign of arrow appeared at even rates (%50 - %50) after neutral and disgusted facial impressions; and during the interpretational bias modification, sentences and relevant words were superficially related or were not related at all.
Combined Cognitive Bias Modification
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combined Cognitive Bias Modification
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Receiving a psychiatric/psychological treatment
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hacettepe University
OTHER
Istanbul Sabahattin Zaim University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Volkan Koç
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Volkan Koç, PhD
Role: STUDY_CHAIR
Istanbul Sabahattin Zaim University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Volkan Koç
Küçükçekmece, Istanbul, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IstanbulSZU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.